BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38547090)

  • 1. Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results.
    Bae JS; Lee JY; Chung HH; Lee M; Jeon MJ; Kim H; Kim HS; Kim K; Lee CS; Son K; Han JK
    PLoS One; 2024; 19(3):e0301193. PubMed ID: 38547090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of exercise on high-intensity focused ultrasound treatment efficacy in uterine fibroids and adenomyosis: a retrospective study.
    Huang X; Yu D; Zou M; Wang L; Xing HR; Wang Z
    BJOG; 2017 Aug; 124 Suppl 3():46-52. PubMed ID: 28856860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
    Guo Y; Duan H; Cheng J; Zhang Y
    BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: A review of 9988 cases.
    Chen J; Chen W; Zhang L; Li K; Peng S; He M; Hu L
    Ultrason Sonochem; 2015 Nov; 27():671-676. PubMed ID: 26093678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 500 Cases of High-intensity Focused Ultrasound (HIFU) Ablated Uterine Fibroids and Adenomyosis.
    Jeng CJ; Ou KY; Long CY; Chuang L; Ker CR
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):865-871. PubMed ID: 33218403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is High-intensity Focused Ultrasound Effective for the Treatment of Adenomyosis? A Systematic Review and Meta-analysis.
    Marques ALS; Andres MP; Kho RM; Abrão MS
    J Minim Invasive Gynecol; 2020 Feb; 27(2):332-343. PubMed ID: 31377454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Predictors of Long-term Success in Ultrasound-guided High-intensity Focused Ultrasound Ablation Treatment for Adenomyosis: A Retrospective Study.
    Liu X; Wang W; Wang Y; Wang Y; Li Q; Tang J
    Medicine (Baltimore); 2016 Jan; 95(3):e2443. PubMed ID: 26817877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
    Lee JS; Hong GY; Lee KH; Kim TE
    BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
    Cai Y; Sun Y; Xu F; Wu Y; Ren C; Hao X; Gao B; Cao Q
    Sci Rep; 2023 Jun; 13(1):9903. PubMed ID: 37336924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portable ultrasound-guided high-intensity focused ultrasound with functions for safe and rapid ablation: prospective clinical trial for uterine fibroids-short-term and long-term results.
    Lee JY; Chung HH; Kang SY; Park EJ; Park DH; Son K; Han JK
    Eur Radiol; 2020 Mar; 30(3):1554-1563. PubMed ID: 31705252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High intensity focused ultrasound treatment for adenomyosis: comparison of efficacy based on MRI features.
    Zhao Y; Luo S; Liu Y; He Y; Liu X; Guohua H; He J
    Int J Hyperthermia; 2023; 40(1):2197574. PubMed ID: 37031960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasound for evaluation of high-intensity focused ultrasound treatment of benign uterine diseases: retrospective analysis of contrast safety.
    Cheng CQ; Zhang RT; Xiong Y; Chen L; Wang J; Huang GH; Li KQ; Zhang L; Bai J
    Medicine (Baltimore); 2015 Apr; 94(16):e729. PubMed ID: 25906100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound in the management of adenomyosis: long-term results from a single center.
    Li X; Zhu X; He S; Jiang Z; Li H; Tian X; Long W; Xue M; Deng X; Ye M
    Int J Hyperthermia; 2021; 38(1):241-247. PubMed ID: 33602049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging features influencing high-intensity focused ultrasound ablation of adenomyosis with a nonperfused volume ratio of ≥90% as a measure of clinical treatment success: retrospective multivariate analysis.
    Keserci B; Duc NM
    Int J Hyperthermia; 2018; 35(1):626-636. PubMed ID: 30307340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment bowel manipulation during ultrasound-guided high-intensity focused ultrasound therapy for posterior wall uterine masses.
    Wu MH; Zhang Y; Chen D; Zhou N; Li H; Peng L; Huang MS; Kuo TC
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1078-1083. PubMed ID: 34794741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective ablation therapy of adenomyosis with ultrasound-guided high-intensity focused ultrasound.
    Zhang X; Li K; Xie B; He M; He J; Zhang L
    Int J Gynaecol Obstet; 2014 Mar; 124(3):207-11. PubMed ID: 24380611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of high-intensity focused ultrasound for the treatment of internal and external adenomyosis based on magnetic resonance imaging classification.
    Xu F; Lin Z; Wang Y; Gong C; He M; Guo Q; Wang Z; Lian Z
    Int J Hyperthermia; 2023; 40(1):2211268. PubMed ID: 37202156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: A single center experience from the Republic of Korea.
    Lee JS; Hong GY; Park BJ; Kim TE
    Ultrason Sonochem; 2015 Nov; 27():682-687. PubMed ID: 26072367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of ultrasound-guided high-intensity focused ultrasound ablation for diffuse adenomyosis: A retrospective cohort study.
    Feng Y; Hu L; Chen W; Zhang R; Wang X; Chen J
    Ultrason Sonochem; 2017 May; 36():139-145. PubMed ID: 28069193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis.
    Xu Y; Zhou Z; Wang H; Shao L; Liu G
    J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):224-231. PubMed ID: 33661158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.